TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.86
-0.34 (-3.04%)
At close: Sep 12, 2025, 3:56 PM
10.94
0.74%
After-hours: Sep 12, 2025, 07:45 PM EDT
TransCode Therapeutics Revenue
TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
7
Market Cap
9.05M
Revenue Chart
History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 0 | n/a |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |
Dec 31, 2019 | 0 | n/a |
Dec 31, 2018 | 0 | n/a |